{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:26:11Z","timestamp":1794965171286,"version":"4.9.1"},"reference-count":67,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T00:00:00Z","timestamp":1664668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Despite the large body of research on sex differences in pain, there is a lack of translation to real-world pain management. Our aim was to analyse the sex differences in the analgesic response to oxycodone\/naloxone (OXN) and tapentadol (TAP), in comparison with other opioids (OPO) commonly prescribed for chronic non-cancer pain (CNCP). An observational and cross-sectional study was conducted on ambulatory CNCP patients (n = 571). Sociodemographic, clinical (pain intensity, relief, and quality of life), safety (adverse events (AEs), adverse drug reactions), hospital frequentations and pharmacological (morphine equivalent daily dose (MEDD)) variables were collected. Multiple linear regressions were carried out to assess the association between sex and outcomes. Sex differences were observed, with lower female tolerability and higher hospital frequentation, especially in the OXN group (OR AEs report = 2.8 [1.8\u20134.4], p &lt; 0.001). Here, females showed higher hospital use (23% hospital admission, 30% prescription change, p &lt; 0.05), requiring a higher MEDD (127 \u00b1 103 mg\/day, p &lt; 0.05), compared to OXN men. Regardless of the opioid group, CNCP women were significantly older than men (three years), with significantly higher benzodiazepine use (OR = 1.6 [1.1\u20132.3]), more constipation (OR = 1.34 [0.93\u20131.90]) and headache (OR = 1.45 [0.99\u20132.13]) AEs, than men who were more likely to refer sexual dysfunction (OR = 2.77 [1.53\u20135.01]), and loss of libido (OR = 1.93 [1.22\u20133.04]). Sex-differences were found related to poorer female drug tolerability and higher hospital resources, even worst in OXN female users. Other differences related to older female ages and benzodiazepine prescription, need to be further analysed from a gender perspective.<\/jats:p>","DOI":"10.3390\/biomedicines10102468","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:07:43Z","timestamp":1665187663000},"page":"2468","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Sex Differences in Oxycodone\/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4697-2783","authenticated-orcid":false,"given":"Jordi","family":"Barrachina","sequence":"first","affiliation":[{"name":"Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), c\/Pintor Baeza, 12, 03010 Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Margarit","sequence":"additional","affiliation":[{"name":"Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), c\/Pintor Baeza, 12, 03010 Alicante, Spain"},{"name":"Pain Unit, Department of Health of Alicante\u2014General Hospital, c\/Pintor Baeza, 12, 03010 Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0048-9451","authenticated-orcid":false,"given":"Javier","family":"Muriel","sequence":"additional","affiliation":[{"name":"Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), c\/Pintor Baeza, 12, 03010 Alicante, Spain"},{"name":"Pain Unit, Department of Health of Alicante\u2014General Hospital, c\/Pintor Baeza, 12, 03010 Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1280-6418","authenticated-orcid":false,"given":"Vicente","family":"L\u00f3pez-Gil","sequence":"additional","affiliation":[{"name":"Occupational Observatory, Miguel Hern\u00e1ndez University of Elche, Avda. de la Universidad s\/n, 03202 Elche, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1792-9129","authenticated-orcid":false,"given":"Santiago","family":"L\u00f3pez-Gil","sequence":"additional","affiliation":[{"name":"Occupational Observatory, Miguel Hern\u00e1ndez University of Elche, Avda. de la Universidad s\/n, 03202 Elche, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7345-448X","authenticated-orcid":false,"given":"Pura","family":"Ballester","sequence":"additional","affiliation":[{"name":"Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), c\/Pintor Baeza, 12, 03010 Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mira-Lorente","sequence":"additional","affiliation":[{"name":"Occupational Observatory, Miguel Hern\u00e1ndez University of Elche, Avda. de la Universidad s\/n, 03202 Elche, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8739-0456","authenticated-orcid":false,"given":"Laura","family":"Agull\u00f3","sequence":"additional","affiliation":[{"name":"Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), c\/Pintor Baeza, 12, 03010 Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2385-3749","authenticated-orcid":false,"given":"Ana M.","family":"Peir\u00f3","sequence":"additional","affiliation":[{"name":"Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), c\/Pintor Baeza, 12, 03010 Alicante, Spain"},{"name":"Department of Pharmacology, Paediatrics and Organic Chemistry, Miguel Hern\u00e1ndez University of Elche, Crta. Nacional, N-332. s\/n, 03505 Sant Joan, Spain"},{"name":"Clinical Pharmacology Unit, Department of Health of Alicante\u2014General Hospital, c\/Pintor Baeza, 12, 03010 Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"104447","DOI":"10.1016\/j.phrs.2019.104447","article-title":"Sex Differences in the Response to Opioids for Pain Relief: A Systematic Review and Meta-Analysis","volume":"148","author":"Pisanu","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.maturitas.2019.09.004","article-title":"Gender, Mental Health and Ageing","volume":"129","author":"Kiely","year":"2019","journal-title":"Maturitas"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/AJP.0000000000000824","article-title":"Gender Bias and Genotype Influence on Opioid Safety Profile in Chronic Low Back Pain","volume":"36","author":"Margarit","year":"2020","journal-title":"Clin. J. Pain"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0147-9563(95)80020-4","article-title":"Gender Bias in the Diagnosis and Treatment of Coronary Artery Disease","volume":"24","author":"Beery","year":"1995","journal-title":"Heart Lung"},{"key":"ref_5","first-page":"71","article-title":"Sex Differences in Associations Between CYP2D6 Phenotypes and Response to Opioid Analgesics","volume":"13","author":"Lopes","year":"2020","journal-title":"Pharmgenomics Pers. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6358624","DOI":"10.1155\/2018\/6358624","article-title":"\u201cBrave Men\u201d and \u201cEmotional Women\u201d: A Theory-Guided Literature Review on Gender Bias in Health Care and Gendered Norms towards Patients with Chronic Pain","volume":"2018","author":"Samulowitz","year":"2018","journal-title":"Pain Res. Manag."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/pme.12380","article-title":"Personalized Oxycodone Dosing: Using Pharmacogenetic Testing and Clinical Pharmacokinetics to Reduce Toxicity Risk and Increase Effectiveness","volume":"15","author":"Linares","year":"2014","journal-title":"Pain Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.phrs.2016.04.012","article-title":"Gender Difference in Prescription Opioid Abuse: A Focus on Oxycodone and Hydrocodone","volume":"108","author":"Graziani","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/B978-0-444-53630-3.00009-9","article-title":"Sex and Gender Differences in Pain and Analgesia","volume":"186","author":"Mogil","year":"2010","journal-title":"Prog. Brain Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1550-8579(05)80042-7","article-title":"Sex Differences in Pain Perception","volume":"2","year":"2005","journal-title":"Gend. Med."},{"key":"ref_11","first-page":"184","article-title":"Gender Differences in Pain and Its Relief","volume":"52","author":"Pieretti","year":"2016","journal-title":"Ann. Ist. Super. Sanita"},{"key":"ref_12","first-page":"169","article-title":"Gender Differences in Pain","volume":"14","author":"Dao","year":"2000","journal-title":"J. Orofac. Pain"},{"key":"ref_13","unstructured":"Canadian Institutes of Health Research (2018). Science Is Better with Sex and Gender. Strategic Plan 2018\u20132023, Canadian Institutes of Health Research."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1517\/13543784.2011.563236","article-title":"Naloxone as Part of a Prolonged Release Oxycodone\/Naloxone Combination Reduces Oxycodone-Induced Slowing of Gastrointestinal Transit in Healthy Volunteers","volume":"20","author":"Smith","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/2049463716657363","article-title":"Is Tapentadol Different from Classical Opioids? A Review of the Evidence","volume":"10","author":"Langford","year":"2016","journal-title":"Br. J. Pain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/2042098618760939","article-title":"Spontaneously Reported Adverse Drug Events Related to Tapentadol and Oxycodone\/Naloxone in Australia","volume":"9","author":"Abeyaratne","year":"2018","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fpsyt.2019.00314","article-title":"Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia","volume":"10","author":"Amato","year":"2019","journal-title":"Front. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2147\/JPR.S190154","article-title":"Tapentadol: An Overview of the Safety Profile","volume":"12","author":"Polati","year":"2019","journal-title":"J. Pain Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jpain.2008.06.014","article-title":"Analgesic Efficacy and Safety of Oxycodone in Combination with Naloxone as Prolonged Release Tablets in Patients with Moderate to Severe Chronic Pain","volume":"9","author":"Vondrackova","year":"2008","journal-title":"J. Pain"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e044157","DOI":"10.1136\/bmjopen-2020-044157","article-title":"Sex Differences in Type and Occurrence of Adverse Reactions to Opioid Analgesics: A Retrospective Cohort Study","volume":"11","author":"Lopes","year":"2021","journal-title":"BMJ Open"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10126","DOI":"10.1038\/s41598-022-13085-5","article-title":"Oxycodone\/Naloxone vs. Tapentadol in Real-World Chronic Non-Cancer Pain Management: An Observational and Pharmacogenetic Study","volume":"12","author":"Barrachina","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_22","unstructured":"(2022, September 09). European Monitoring Centre for Drugs and Drug Addiction Pregnancy and Opioid Use: Strategies for Treatment. Available online: https:\/\/www.emcdda.europa.eu\/publications\/emcdda-papers\/pregnacy-opioid-use_en."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic Pain: Diagnosis, Pathophysiological Mechanisms, and Treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","article-title":"Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage","volume":"32","author":"Costigan","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic Pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.26502\/aimr.0061","article-title":"Global Pain State Questionnaire: Reliability, Validity, and Gender Gap","volume":"4","author":"Barrachina","year":"2021","journal-title":"Arch. Intern. Med. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1067\/mem.2001.118012","article-title":"Clinically Significant Changes in Pain along the Visual Analog Scale","volume":"38","author":"Bird","year":"2001","journal-title":"Ann. Emerg. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/emj.18.3.205","article-title":"The Minimum Clinically Significant Difference in Visual Analogue Scale Pain Score Does Not Differ with Severity of Pain","volume":"18","author":"Kelly","year":"2001","journal-title":"Emerg. Med. J."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Sino, C.G., Stuffken, R., Heerdink, E.R., Schuurmans, M.J., Souverein, P.C., and Egberts, T.C. (2013). The Association between Prescription Change Frequency, Chronic Disease Score and Hospital Admissions: A Case Control Study. BMC Pharmacol. Toxicol., 14.","DOI":"10.1186\/2050-6511-14-39"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/0269216311406577","article-title":"Conversion Ratios for Opioid Switching in the Treatment of Cancer Pain: A Systematic Review","volume":"25","author":"Mercadante","year":"2011","journal-title":"Palliat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1185\/03007995.2013.791617","article-title":"Opioid Switching from and to Tapentadol Extended Release in Cancer Patients: Conversion Ratio with Other Opioids","volume":"29","author":"Mercadante","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_32","unstructured":"(2022, July 26). Faculty of Pain Medicine of the Royal College of Anaesthetists Dose Equivalents and Changing Opioids. Available online: https:\/\/fpm.ac.uk\/opioids-aware-structured-approach-opioid-prescribing\/dose-equivalents-and-changing-opioids."},{"key":"ref_33","first-page":"2","article-title":"Neuromodulators for Pain Management in Rheumatoid Arthritis","volume":"1","author":"Richards","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_34","first-page":"52","article-title":"Impact of Genetic Factors on Severity of Side Effects of Opioids in Patients after Major Surgical Interventions","volume":"5","author":"Boiarkina","year":"2014","journal-title":"Klin. Khirurhiia"},{"key":"ref_35","unstructured":"(2021, March 17). Spanish Agency of Medicines and Health Products (AEMPS-CIMA) Online Information Center of Medicines of Spanish Agency of Medicines and Health Products (AEMPS-CIMA). Available online: https:\/\/cima.aemps.es\/cima\/publico\/home.html."},{"key":"ref_36","first-page":"330","article-title":"Making Sense of Biostatistics: Types of Nonprobability Sampling","volume":"10","author":"Mathieson","year":"2014","journal-title":"J. Clin. Res. Best Pract."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41397-019-0118-9","article-title":"Gender Based Differences, Pharmacogenetics and Adverse Events in Chronic Pain Management","volume":"20","author":"Planelles","year":"2020","journal-title":"Pharmacogenomics J."},{"key":"ref_38","first-page":"3","article-title":"Use of Opioid Analgesics for the Treatment of Chronic Noncancer Pain\u2014A Consensus Statement and Guidelines from the Canadian Pain Society, 2002","volume":"5","author":"Jovey","year":"2019","journal-title":"Pain Pract."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/pme.12787","article-title":"Prevalence and Trends of Concurrent Opioid Analgesic and Benzodiazepine Use Among Veterans Affairs Patients with Post-Traumatic Stress Disorder, 2003-2011","volume":"16","author":"Hawkins","year":"2015","journal-title":"Pain Med."},{"key":"ref_40","unstructured":"United Nations (2020). Informe de La Junta Internacional de Fiscalizaci\u00f3n de Estupefacientes Correspondientes a 2019, United Nations."},{"key":"ref_41","unstructured":"Sistema Nacional de Salud, and Ministerio de Sanidad (2018). Prestaci\u00f3n Farmac\u00e9utica En El Sistema Nacional de Salud. Informe Anual Del Sistema Nacional de Salud 2018, Ministerio de Sanidad."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/pds.3825","article-title":"Exposure to Benzodiazepines (Anxiolytics, Hypnotics and Related Drugs) in Seven European Electronic Healthcare Databases: A Cross-National Descriptive Study from the PROTECT-EU Project","volume":"25","author":"Huerta","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jad.2014.11.058","article-title":"Gender Differences in the Treatment of Patients with Bipolar Disorder: A Study of 7354 Patients","volume":"174","author":"Karanti","year":"2015","journal-title":"J. Affect. Disord."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.eurpsy.2015.05.001","article-title":"Gender Differences in Psychotropic Use across Europe: Results from a Large Cross-Sectional, Population-Based Study","volume":"30","author":"Boyd","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"ref_45","unstructured":"United Nations\u2014Office on Drugs and Crime (2004). Substance Abuse Treatment and Care for Women: Case Studies and Lessons Learned, United Nations."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.36076\/ppj.2013\/16\/E685","article-title":"Drug Therapy for the Treatment of Chronic Nonspecific Low Back Pain: Systematic Review and Meta-Analysis","volume":"16","author":"Chung","year":"2013","journal-title":"Pain Physician"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00002508-200305000-00005","article-title":"Sex Differences in Opioid Analgesia: \u201cFrom Mouse to Man\u201d","volume":"19","author":"Craft","year":"2003","journal-title":"Clin. J. Pain"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bcpt.13155","article-title":"Pharmacogenetics and Prediction of Adverse Events in Prescription Opioid Use Disorder Patients","volume":"124","author":"Muriel","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_49","unstructured":"(2021, October 21). Centers for Disease Control and Prevention Understanding the Epidemic|CDC\u2019s Response to the Opioid Overdose Epidemic|CDC, Available online: https:\/\/www.cdc.gov\/opioids\/basics\/epidemic.html."},{"key":"ref_50","unstructured":"U.S. Department of Health and Human Services (2017). Final Report: Opioid Use, Misuse, and Overdose in Women."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.sbspro.2010.07.090","article-title":"Pain Sensitivity among Women with Low Estrogen Levels","volume":"5","author":"Nikolov","year":"2010","journal-title":"Procedia Soc. Behav. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/sjop.12545","article-title":"Physicians\u2019 Gender Bias in the Diagnostic Assessment of Medically Unexplained Symptoms and Its Effect on Patient-Physician Relations","volume":"60","year":"2019","journal-title":"Scand. J. Psychol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Campesi, I., Montella, A., Seghieri, G., and Franconi, F. (2021). The Person\u2019s Care Requires a Sex and Gender Approach. J. Clin. Med., 10.","DOI":"10.3390\/jcm10204770"},{"key":"ref_54","first-page":"109","article-title":"Sesgos de G\u00e9nero En El Esfuerzo Terap\u00e9utico: De La Investigaci\u00f3n a La Atenci\u00f3n Sanitaria","volume":"44","year":"2020","journal-title":"Farm. Hosp."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/14740338.2020.1849135","article-title":"Introducing Sexual Dysfunction in Mental Care","volume":"20","author":"Gombert","year":"2021","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e002378","DOI":"10.1136\/bmjopen-2012-002378","article-title":"Differences in Drug Utilisation between Men and Women: A Cross-Sectional Analysis of All Dispensed Drugs in Sweden","volume":"3","author":"Loikas","year":"2013","journal-title":"BMJ Open"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Orlando, V., Mucherino, S., Guarino, I., Guerriero, F., Trama, U., and Menditto, E. (2020). Gender Differences in Medication Use: A Drug Utilization Study Based on Real World Data. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17113926"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13293-021-00377-0","article-title":"Sex Differences Associated with Adverse Drug Reactions Resulting in Hospital Admissions","volume":"12","author":"Hendriksen","year":"2021","journal-title":"Biol. Sex Differ."},{"key":"ref_59","unstructured":"L\u00f3pez-Ramal, A. (2022). Comunicaci\u00f3n Telef\u00f3nica de Eventos Adversos En La Terap\u00e9utica Del Dolor: Diferencias Por Sexo y Gen\u00e9tica, Miguel Hern\u00e1ndez University."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ahj.2009.12.040","article-title":"Gender Differences in Adverse Outcomes after Contemporary Percutaneous Coronary Intervention: An Analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Percutaneous Coronary Intervention Registry","volume":"159","author":"Duvernoy","year":"2010","journal-title":"Am. Heart J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1157\/13062260","article-title":"Sesgo de G\u00e9nero En El Esfuerzo Terap\u00e9utico","volume":"18","year":"2004","journal-title":"Gac. Sanit."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1034\/j.1600-0412.2003.00168.x","article-title":"Diagnostic Delay in Women with Pain and Endometriosis","volume":"82","author":"Husby","year":"2003","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1097\/j.pain.0000000000000536","article-title":"Health Care Providers\u2019 Judgments in Chronic Pain: The Influence of Gender and Trustworthiness","volume":"157","author":"Prkachin","year":"2016","journal-title":"Pain"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/pme.12151","article-title":"Perceived Stereotyping and Seeking Care for Chronic Vulvar Pain","volume":"14","author":"Nguyen","year":"2013","journal-title":"Pain Med."},{"key":"ref_65","first-page":"331","article-title":"Correlation study between diagnostic opportunity and pain severity in patients with fibromyalgia who enter the Nononcological Chronic Pain Unit at the San Borja Arriar\u00e1n Clinical Hospital","volume":"26","year":"2019","journal-title":"Rev. La Soc. Espa\u00f1ola Del Dolor"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/aas.13243","article-title":"Health Benefits of an Adverse Events Reporting System for Chronic Pain Patients Using Long-Term Opioids","volume":"63","author":"Planelles","year":"2019","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bpg.2010.11.001","article-title":"What Is Necessary to Diagnose Constipation?","volume":"25","author":"Rao","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/10\/2468\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:45:44Z","timestamp":1760143544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/10\/2468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,2]]},"references-count":67,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["biomedicines10102468"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10102468","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,2]]}}}